| Literature DB >> 12519068 |
Silvia Selleri1, Fabrizio Bruni, Camilla Costagli, Annarella Costanzo, Gabriella Guerrini, Giovanna Ciciani, Paola Gratteri, Claudia Bonaccini, Petra Malmberg Aiello, François Besnard, Stephane Renard, Barbara Costa, Claudia Martini.
Abstract
New 3-aryl-6-(3-thienyl)pyrazolo[1,5-a]pyrimidin-7-ones (2a-j) are synthesized and evaluated in vitro on Bz/GABA(A) receptors and on recombinant benzodiazepine receptors (alpha x beta 2/3 gamma 2; x = 1-3, 5) expressed in HEK293 cells. SAR studies on the new compounds are conducted and molecular modeling is accomplished to better investigate requirements leading to subtype selectivity. Some of the synthesized compounds are tested in vivo to explore their pharmacological effect as a consequence of their high alpha 1 beta 2 gamma 2 subtype selectivity observed in vitro.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12519068 DOI: 10.1021/jm020999w
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446